Studies have reported that the haplotype HLA‐B*0702‐DRB1*1501/HLADQB1*0602 increases the risk of cervical carcinoma, whereas the haplotype HLA‐B*1501/HLA‐DRB1*1301/HLA‐DQA1*0103/HLA‐DQB1*0603 protects from the risk of the disease progression.21, 23, 24, 48, 49, 50, 51, 52. This evidence concerns the gene HLA-DRB1 and cervical carcinoma.